Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mwinga

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Lancet (London, England)|September 23, 1995
Treatment in developing countriesA Mwinga
Annals of the New York Academy of Sciences|January 25, 2002
Drug-resistant tuberculosis in AfricaA Mwinga
Lancet (London, England)|February 24, 2001
Tropical diseases and the 10/90 gapM Bosman, A Mwinga
Lancet (London, England)|August 25, 1999
An African perspective on the threat of tuberculosis and HIV/AIDS--can despair be turned to hope?C Chintu, A Mwinga
Tropical Medicine & International Health : TM & IH|July 2, 2004
Prospects for new tuberculosis treatment in AfricaA Mwinga, P Bernard Fourie
Clinical Radiology|December 10, 1997
Radiological features of pulmonary tuberculosis in 963 HIV-infected adults at three Central African HospitalsE Tshibwabwa-Tumba, A Mwinga, J O Pobee, et al.
Mykosen|August 1, 1986
Naftifine solution (1%) in the treatment of pityriasis versicolor in ZambiaS K Hira, M S Abraham, A Mwinga, et al.
Public Health Action|May 27, 2024
Designing an operational research TB training program in ZambiaR Kumar, J Bwembya, V Makwambeni, et al.
BMJ (Clinical Research Ed.)|March 31, 1998
Ethics and international research. Obtaining informed consent for trials in Africa is possibleP Godfrey-Faussett, A Mwinga, M Hosp, et al.
BMJ (Clinical Research Ed.)|November 5, 1994
Tuberculosis and slim disease in AfricaP Godfrey-Faussett, A Mwinga, M Hosp, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Lancet (London, England)|September 23, 1995
Treatment in developing countriesA Mwinga
Annals of the New York Academy of Sciences|January 25, 2002
Drug-resistant tuberculosis in AfricaA Mwinga
Lancet (London, England)|February 24, 2001
Tropical diseases and the 10/90 gapM Bosman, A Mwinga
Lancet (London, England)|August 25, 1999
An African perspective on the threat of tuberculosis and HIV/AIDS--can despair be turned to hope?C Chintu, A Mwinga
Tropical Medicine & International Health : TM & IH|July 2, 2004
Prospects for new tuberculosis treatment in AfricaA Mwinga, P Bernard Fourie
Clinical Radiology|December 10, 1997
Radiological features of pulmonary tuberculosis in 963 HIV-infected adults at three Central African HospitalsE Tshibwabwa-Tumba, A Mwinga, J O Pobee, et al.
Mykosen|August 1, 1986
Naftifine solution (1%) in the treatment of pityriasis versicolor in ZambiaS K Hira, M S Abraham, A Mwinga, et al.
Public Health Action|May 27, 2024
Designing an operational research TB training program in ZambiaR Kumar, J Bwembya, V Makwambeni, et al.
BMJ (Clinical Research Ed.)|March 31, 1998
Ethics and international research. Obtaining informed consent for trials in Africa is possibleP Godfrey-Faussett, A Mwinga, M Hosp, et al.
BMJ (Clinical Research Ed.)|November 5, 1994
Tuberculosis and slim disease in AfricaP Godfrey-Faussett, A Mwinga, M Hosp, et al.
Pageof 3